emoxypine succinate has been researched along with Disease Models, Animal in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 16 (76.19) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skachilova, SY; Voronina, TA; Yasnetsov, VV | 1 |
| Gudasheva, TA; Povarnina, PY; Seredenin, SB; Volkova, AA | 1 |
| Germanova, EL; Kirova, YI; Lukyanova, LD | 1 |
| Avdyunina, NI; Gan'shina, TS; Mirzoyan, RS; Pyatin, BM; Turilova, AI | 1 |
| Iakubovskiĭ, SV; Kondratenko, GG; Leonovich, SI; Popova, II | 1 |
| Faĭzullin, RM; Miroshnichenko, IIu; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Faĭzullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, II; Priakhina, KE; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Faizullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, IA | 1 |
| Chelnaya, NA; Karsanova, SK; Skachilova, SY; Tsublova, EG; Yasnetsov, VV | 1 |
| Ivanov, YV; Karsanova, SK; Skachilova, SY; Tsublova, EG; Yasnetsov, VV | 1 |
| Beliaev, AN; Beliaev, SA; Bukharkin, MN; Khvostunova, SI; Kostin, SV; Mel'nikova, DV; Mokshina, EI | 1 |
| Iasnetsov, VV; Voronina, TA | 1 |
| Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA | 1 |
| Gan'shina, TS; Gnezdilova, AV; Lebedeva, MA; Mirzoian, RS | 1 |
| Kliuĭko, DA; Korik, VE; Zhidkov, SA | 1 |
| Avdiunina, NI; Gan'shina, TS; Gnezdilova, AV; Gorbunov, AA; Kurdiumov, IN; Mirzoian, RS; Piatin, BM | 1 |
| Gan'shina, TS; Gorbunov, AA; Mirzoian, RS; Turilova, AI | 1 |
| Avakian, GN; Barskov, IV; Gusev, Ei; Katunina, EA; Kuznetsov, NV; Malykhina, EA; nerobkova, LN; Voronina, TA | 1 |
| Kraĭneva, VA | 1 |
| Inchina, VI; Semenova, EV | 1 |
| Bazanov, GA | 1 |
21 other study(ies) available for emoxypine succinate and Disease Models, Animal
| Article | Year |
|---|---|
Neuroprotective and Antiamnestic Effects of a New Drug Emopag in Rats.
Topics: Amnesia; Animals; Brain Ischemia; Disease Models, Animal; Glutamates; Male; Memory; Neuroprotective Agents; Picolines; Pyridines; Rats; Thiadiazoles | 2019 |
Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Injections, Intraperitoneal; Middle Cerebral Artery; Molecular Mimicry; Neuroprotective Agents; Neurotrophin 3; Picolines; Rats; Rats, Wistar; Stroke | 2017 |
The Role of Succinate in Regulation of Immediate HIF-1α Expression in Hypoxia.
Topics: Adaptation, Physiological; Altitude Sickness; Animals; Cerebral Cortex; Citric Acid Cycle; Disease Models, Animal; Electron Transport Complex I; Electron Transport Complex II; gamma-Aminobutyric Acid; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Phenobarbital; Picolines; Rats; Rats, Inbred Strains; Semicarbazides; Signal Transduction; Succinate Dehydrogenase; Succinic Acid | 2018 |
[ANTIARRHYTHMIC EFFECTS OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE IN COMPARISON TO MEXIDOL.]
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Chloride; Disease Models, Animal; Male; Picolines; Pyridines; Rats | 2016 |
[Changes of oxidative homeostasis in acute experimental cholecystitis].
Topics: Animals; Antioxidants; Blood Proteins; Catalase; Cholecystitis, Acute; Disease Models, Animal; Female; Guinea Pigs; Injections, Intramuscular; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Oxidation-Reduction; Oxidative Stress; Picolines; Succinates; Superoxide Dismutase | 2012 |
[The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].
Topics: Amitriptyline; Animals; Behavior, Animal; Disease Models, Animal; Female; Humans; Hypnotics and Sedatives; Male; Meglumine; Mice; Motor Activity; Obsessive-Compulsive Disorder; Picolines; Psychotropic Drugs; Succinates; Thioctic Acid | 2014 |
[The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
Topics: Acute Disease; Animals; Brain Ischemia; Disease Models, Animal; Female; Male; Meglumine; Mice; Picolines; Pyridines; Succinates; Thioctic Acid | 2014 |
[Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
Topics: Animals; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Female; Male; Meglumine; Picolines; Psychotropic Drugs; Pyridines; Rats; Succinates; Succinic Acid | 2015 |
[VESTIBULAR AND THERMOPROTECTIVE PROPERTIES OF A NEW ACTOPROTECTOR].
Topics: Animals; Antioxidants; Body Temperature Regulation; Disease Models, Animal; Male; Mice; Motion Sickness; Picolines; Rats; Vestibule, Labyrinth | 2015 |
[STUDYING SOME PHARMACOLOGICAL EFFECTS OF NEW 3-HYDROXYPYRIDINE DERIVATIVE].
Topics: Adamantane; Amnesia; Animals; Animals, Outbred Strains; Anticonvulsants; Benzimidazoles; Brain Ischemia; Disease Models, Animal; Exercise Test; Gluconeogenesis; Male; Mice; Neuroprotective Agents; Nootropic Agents; Physical Conditioning, Animal; Picolines; Piracetam; Rats; Swimming; Tryptophan | 2016 |
Effectiveness of intraportal mexidol infusions in the treatment of obstructive jaundice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Follow-Up Studies; Infusions, Intravenous; Jaundice, Obstructive; Lipid Peroxidation; Liver; Luminescent Measurements; Picolines; Portal Vein; Treatment Outcome | 2009 |
[Antihypoxic and antiamnesic effects of mexidol and semax].
Topics: Adrenocorticotropic Hormone; Amnesia; Animals; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoxia; Mice; Mitochondria; Neuroprotective Agents; Oxygen Consumption; Peptide Fragments; Picolines; Psychotropic Drugs; Pyramidal Cells; Rats; Rats, Wistar; Time Factors | 2010 |
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hippocampus; Learning; Lipid Metabolism; Lipid Peroxidation; Male; Meglumine; Motor Activity; Neurons; Neuroprotective Agents; Nootropic Agents; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2011 |
[Effect of mexidol on combined vascular pathology of brain and heart].
Topics: Animals; Brain; Cerebrovascular Circulation; Coronary Occlusion; Disease Models, Animal; Ischemic Attack, Transient; Male; Myocardial Infarction; Neuroprotective Agents; Parietal Lobe; Picolines; Rats | 2011 |
[Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis].
Topics: Acute Disease; Animals; Antioxidants; Disease Models, Animal; Drug Combinations; Flavin Mononucleotide; Guinea Pigs; Injections, Intraperitoneal; Inosine Diphosphate; Niacinamide; Oxygen; Oxygen Consumption; Pancreas; Pancreatitis; Partial Pressure; Picolines; Succinates; Treatment Outcome | 2011 |
[Influence of 2-ethyl-6-methyl-3-hydroxypyridine hemisuccinate on cerebral blood perfusion in rats under experimental pathology conditions].
Topics: Animals; Antioxidants; Aza Compounds; Brain; Brain Ischemia; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery, Internal; Cerebrovascular Circulation; Disease Models, Animal; Drug Combinations; Male; Neuroprotective Agents; Picolines; Piperazines; Rats; Serotonin Antagonists; Serotonin Receptor Agonists | 2011 |
[Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
Topics: Animals; Antioxidants; Aza Compounds; Brain; Brain Ischemia; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery, Internal; Cerebrovascular Circulation; Disease Models, Animal; Drug Combinations; Male; Picolines; Piperazines; Rats; Serotonin Antagonists; Serotonin Receptor Agonists; Vasodilator Agents | 2011 |
[Antioxidants in complex treatment of Parkinson's disease].
Topics: Animals; Antioxidants; Brain; Disease Models, Animal; Dopamine Agonists; Drug Therapy, Combination; Electromyography; Female; Male; Muscle, Skeletal; Parkinson Disease; Picolines; Rats | 2006 |
[The experimental study of peculiarities and mechanism of neuroprotective action of mexidol in hemorrhagic stroke].
Topics: Animals; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Learning; Locomotion; Male; Memory; Picolines; Psychotropic Drugs; Rats; Treatment Outcome | 2006 |
[Study of hepatoprotective activity of ethylmethylhydroxypyridine fumarate and lipoate in the experimental toxic hepatitis].
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Liver Function Tests; Male; Malondialdehyde; Mice; Picolines; Protective Agents | 2007 |
[The effect of oxypine on tissue edema in allergic rabbits].
Topics: Animals; Antioxidants; Disease Models, Animal; Edema; Female; Hypersensitivity; Male; Organ Size; Picolines; Rabbits | 1995 |